NNZ 2591 [CAS 847952-38-9]
Partner: MedChemexpress LLC
| CAS No: | 847952-38-9 |
| Applications: | Neuroscience-Neurodegeneration |
| MW: | 194.23 |
| Formula: | C10H14N2O2 |
| SMILES: | C=CC[C@@]12N(CCC2)C(CNC1=O)=O |
| Purity: | 99.98 |
| Description: | NNZ 2591 is a synthetic analogue of a small peptide of cyclic glycine proline (cGP). NNZ 2591 shows orally active and cross the blood-brain barrier. NNZ 2591 shows neuroprotective after ischemic brain injury. NNZ 2591 improves motor function in a rat model of Parkinson's disease. NNZ 2591 has the potential for the research of ischemic brain injury and angelman syndrome[1][2][3]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
